# Dianthus Therapeutics, Inc.: Form 8-K, filed Jan 22, 2024

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2024-01-22
- Accepted by EDGAR: Jan 22, 2024, 07:34 ET
- Period: 2024-01-22
- Accession: 0001193125-24-011681
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312524011681/d699582d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312524011681/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312524011681/d699582d8k.htm

Filed Jan 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-011681. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.
